Evidence map›Paper›PMID 34106369›Full record

ArticleJournal of community health2021

PrEP University: A Multi-Disciplinary University-Based HIV Prevention Education Program.

Sophie M Cannon, Sara Graber, Helen L King, Marvin Hanashiro, Sarah Averbach, David J Moore, Jill Blumenthal

Abstract read
In one paragraph

Article in Journal of community health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sophie M CannonDepartment of Medicine, Antiviral Research Center, UCSD Medical Center, 220 Dickinson Street, Suite A, San Diego, CA, 92103, USA. sophiemcannon@gmail.com.ORCID 0000-0003-1643-6944
Sara GraberDepartment of Medicine, Antiviral Research Center, UCSD Medical Center, 220 Dickinson Street, Suite A, San Diego, CA, 92103, USA.
Helen L KingDepartment of Internal Medicine, UT Southwestern, Dallas, TX, 75390, USA.
Marvin HanashiroDepartment of Medicine, Antiviral Research Center, UCSD Medical Center, 220 Dickinson Street, Suite A, San Diego, CA, 92103, USA.
Sarah AverbachObstetrics, Gynecology and Reproductive Sciences, University of California, San Diego, San Diego, CA, 92103, USA.
David J MooreDepartment of Psychiatry, University of California, San Diego, San Diego, CA, 92103, USA.
Jill BlumenthalDepartment of Medicine, Antiviral Research Center, UCSD Medical Center, 220 Dickinson Street, Suite A, San Diego, CA, 92103, USA.

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAVID J MOORE · 2001 to 2026
$50.4M
UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
NCATS NIH HHS KL2 TR001444NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIH HHS grant number KL2TR001444NIMH NIH HHS P30 MH062512
6 · The paper itself

Abstract

The introduction of emtricitabine/tenofovir diphosphate (FTC/TDF) as pre-exposure prophylaxis (PrEP) for HIV prevention has raised questions regarding which clinicians will serve as prescribers and how providers will be educated about this HIV prevention strategy. We piloted an HIV Prevention Education Program called PrEP University (PrEP U) to address knowledge gaps in HIV prevention among medical trainees. We examined PrEP awareness and assessed learning as a result of the program, measuring knowledge before and after the lectures with an anonymous 5-question multiple choice test. A total of 198 learners participated in PrEP University, which included 127 first year medical students, and post-graduate trainees in internal medicine (n = 23), family medicine (n = 16), OBGYN (n = 13) and pharmacy (n = 19). Prior to PrEP U, 27% of all participants were not aware of PrEP and an additional 8% were unsure if they had heard of it. Knowledge increased significantly after the education program among trainees in OBGYN (2.3 vs 3.8, p < 0.001), pharmacy (1.4 vs 2.5, p = 0.012) and school of medicine (3.3 vs 4.4, p < 0.001), with a trend seen in family medicine (2.7 vs. 3.7, p = 0.067) and internal medicine (2.7 vs 3.4, p = 0.068). Overall, an HIV Prevention Education Program was successfully administered to nearly 200 participants and resulted in improved knowledge of HIV prevention and PrEP across. Pharmacists and OBGYN physicians are two groups with an expanding role in the use of PrEP. Similar programs at other medical schools should be implemented to ensure that future physicians and pharmacists are comfortable with PrEP prescription.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisHumansPharmacistsUniversitiesAnti-HIV AgentsHIVLGBTQ healthLGBTQ medical educationPreexposure prophylaxisPrEP

Identifiers

PMID34106369
PMCPMC8595182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.